English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases. Clin J Am Soc Nephrol 2012; 7: 1964–1968 15. Ivanyi B. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med 1990; 114: 986–987 16. JohnsonWJ, Kyle RA, PinedaAA et al. Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med 1990; 150: 863–869 17. Pasquali S, Zucchelli P, Casanova S et al. Renal histological lesions and clinical syndromes in multiplemyeloma. Renal Immunopathology Group. Clin Nephrol 1987; 27: 222–228 18. Pozzi C, Pasquali S, Donini U et al. Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: a review of 50 cases. Report of the Italian Renal Immunopathology Group. Clin Nephrol 1987; 28: 1–9 19. Fish R, Pinney J, Jain P et al. The incidence of major hemorrhagic complications after renal biopsies in patients with monoclonal gammopathies. Clin J Am Soc Nephrol 2010; 5: 1977–1980 20. Soares SM, Fervenza FC, Lager DJ et al. Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: singlecenter experience in 101 patients. Am J Kidney Dis 2008; 52: 1079–1083

Cell-cycle arrest biomarkers: the light at the end of the acute kidney injury tunnel